Analyses of IL-17 expression have revealed that patients with diffuse form of gastric cancer had significantly lower expression of this cytokine in comparison to patients with intestinal tumor form (p = 0.029; Figure 3(a)). This evidence concerns the gene IL17A and intestinal neoplasm.